Evidence map›Paper›PMID 28178960›Full record

ReviewBMC medicine2017

Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.

Branko Malojcic, Panteleimon Giannakopoulos, Farzaneh A Sorond, Elsa Azevedo, Marina Diomedi, Janja Pretnar Oblak, Nicola Carraro, Marina Boban, Laszlo Olah, Stephan J Schreiber and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in BMC medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Alterations in the inflammatory homeostasis of aging-related cardiac dysfunction and Alzheimer's diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Cerebral blood flow regulation and cognitive performance in hypertension.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  12. Article
  13. Article
  14. Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  15. Review
  16. Article
  17. Pathogenesis and research progress in leukoaraiosis.Frontiers in human neuroscience · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 10 countries.

Branko MalojcicDepartment of Neurology, University Hospital Center Zagreb, Zagreb School of Medicine, Kispaticeva 12, 10000, Zagreb, Croatia. branko.malojcic@kbc-zagreb.hr.
Panteleimon GiannakopoulosDepartment of Psychiatry, HUG Belle-Idée, University of Geneva School of Medicine, Geneva, Switzerland.
Farzaneh A SorondDepartment of Neurology, Northwestern University Feinberg School of Medicine Chicago, Chicago, IL, USA.
Elsa AzevedoDepartment of Neurology, São João Hospital Center and Faculty of Medicine of University of Porto, Porto, Portugal.
Marina DiomediCerebrovascular Disease Center, Stroke Unit, University of Rome Tor Vergata, Rome, Italy.
Janja Pretnar OblakDepartment of Vascular Neurology and Intensive Therapy, University Medical Center Ljubljana, Ljubljana, Slovenia.
Nicola CarraroDepartment of Medical Sciences, Clinical Neurology-Stroke Unit, University Hospital, University of Trieste, Trieste, Italy.
Marina BobanDepartment of Neurology, University Hospital Center Zagreb, Zagreb School of Medicine, Kispaticeva 12, 10000, Zagreb, Croatia.
Laszlo OlahDepartment of Neurology, University of Debrecen, Debrecen, Hungary.
Stephan J SchreiberDepartment of Neurology, Charite - Universitätsmedizin Berlin, Berlin, Germany.
Aleksandra PavlovicNeurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Zsolt GaramiMethodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Nantan M BornsteinNeurology Department, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel.
Bernhard RosengartenDepartment of Neurology, Justus-Liebig-University Giessen, Giessen, Germany.
University Hospital Centre Zagreb · HRCharité - Universitätsmedizin Berlin · DEHospital de São João · PTHouston Methodist · USLjubljana University Medical Centre · SINorthwestern University · USTel Aviv Sourasky Medical Center · ILUniversity of Belgrade · RSUniversity of Debrecen · HUUniversity of Geneva · CHUniversity of Giessen · DEUniversity of Rome Tor Vergata · ITUniversity of Trieste · IT

Funding

Cerebral Small Vessels in Motor and Cognitive Decline: Neuroimaging Signatures of Vulnerability & ResilienceR01NS085002 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FARZANEH A SOROND · 2014 to 2026
$3.8M
NINDS NIH HHS R01 NS085002
6 · The paper itself

Abstract

backgroundThe vascular contributions to neurodegeneration and neuroinflammation may be assessed by magnetic resonance imaging (MRI) and ultrasonography (US). This review summarises the methodology for these widely available, safe and relatively low cost tools and analyses recent work highlighting their potential utility as biomarkers for differentiating subtypes of cognitive impairment and dementia, tracking disease progression and evaluating response to treatment in various neurocognitive disorders.

methodsAt the 9th International Congress on Vascular Dementia (Ljubljana, Slovenia, October 2015) a writing group of experts was formed to review the evidence on the utility of US and arterial spin labelling (ASL) as neurophysiological markers of normal ageing, vascular cognitive impairment (VCI) and Alzheimer's disease (AD). Original articles, systematic literature reviews, guidelines and expert opinions published until September 2016 were critically analysed to summarise existing evidence, indicate gaps in current knowledge and, when appropriate, suggest standards of use for the most widely used US and ASL applications.

resultsCerebral hypoperfusion has been linked to cognitive decline either as a risk or an aggravating factor. Hypoperfusion as a consequence of microangiopathy, macroangiopathy or cardiac dysfunction can promote or accelerate neurodegeneration, blood-brain barrier disruption and neuroinflammation. US can evaluate the cerebrovascular tree for pathological structure and functional changes contributing to cerebral hypoperfusion. Microvascular pathology and hypoperfusion at the level of capillaries and small arterioles can also be assessed by ASL, an MRI signal. Despite increasing evidence supporting the utility of these methods in detection of microvascular pathology, cerebral hypoperfusion, neurovascular unit dysfunction and, most importantly, disease progression, incomplete standardisation and missing validated cut-off values limit their use in daily routine.

conclusionsUS and ASL are promising tools with excellent temporal resolution, which will have a significant impact on our understanding of the vascular contributions to VCI and AD and may also be relevant for assessing future prevention and therapeutic strategies for these conditions. Our work provides recommendations regarding the use of non-invasive imaging techniques to investigate the functional consequences of vascular burden in dementia.

Indexed as

Alzheimer DiseaseCognitive DysfunctionHumansAlzheimer diseaseArterial spin labellingCerebral small vessel diseaseTranscranial Doppler sonographyUltrasonographyVascular cognitive impairmentVascular dementia

Identifiers

PMID28178960
PMCPMC5299782
OpenAlexW2583780090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.